Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia - update of single center study.
Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E, Szotkowski T, Rohon P, Hubacek J, Indrak K, Pikalova Z, Jarosova M, Divoka M, Langova K, Papajik T. Raida L, et al. Among authors: szotkowski t. Neoplasma. 2017;64(5):762-769. doi: 10.4149/neo_2017_515. Neoplasma. 2017. PMID: 28592129
Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression could be an effective approach to patients with acute lymphoblastic leukemia.
Raida L, Rusinakova Z, Szotkowska R, Kuba A, Faber E, Rohon P, Szotkowski T, Hubacek J, Pikalova Z, Jarosova M, Divoka M, Indrak K, Langova K, Skoumalova I, Papajik T. Raida L, et al. Among authors: szotkowski t. Neoplasma. 2015;62(5):805-11. doi: 10.4149/neo_2015_097. Neoplasma. 2015. PMID: 26278139
Prognostic factors and treatment outcome in 1,516 adult patients with de novo and secondary acute myeloid leukemia in 1999-2009 in 5 hematology intensive care centers in the Czech Republic.
Szotkowski T, Muzik J, Voglova J, Koza V, Maaloufova J, Kozak T, Jarosova M, Michalova K, Zak P, Steinerova K, Vydra J, Lanska M, Katrincsakova B, Sicova K, Pavlik T, Dusek L, Indrak K. Szotkowski T, et al. Neoplasma. 2010;57(6):578-89. doi: 10.4149/neo_2010_06_578. Neoplasma. 2010. PMID: 20845997
The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: an analysis of 96 allografted AML patients ≥ 50 years from the Czech acute leukaemia clinical register (alert).
Jindra P, Muzik J, Indrak K, Zak P, Sabty FA, Kozak T, Cetkovsky P, Karas VK, Raida L, Szotkowski T. Jindra P, et al. Among authors: szotkowski t. Neoplasma. 2013;60(5):576-83. doi: 10.4149/neo_2013_075. Neoplasma. 2013. PMID: 23790178
54 results